
GC71219
Plasma kallikrein-IN-4
Also known as N-[(6-amino-2,4-dimethyl-3-pyridinyl)methyl]-1-[(2-methylquinolin-6-yl)methyl]triazole-4-carboxamide
Plasma kallikrein-IN-4 (Example 153) is a plasma kallikrein inhibitor with an IC50 of 0·016 μM against human plasma kallikrein
ChemicalCAS1357954-34-7MW401.46FormulaC22H23N7O
- CAS number
- 1357954-34-7
- Molecular weight
- 401.46
- Formula
- C22H23N7O
- Solubility
- DMSO : 100 mg/mL (249·09 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
- InChIKey
- BYZNGWXDOMLVBH-UHFFFAOYSA-N
- Catalogue number
- GC71219
- Brand
- GLPBIO
Computed properties PubChem CID 58081326 · XLogP 2.4 · TPSA 112 Ų · H-bond donors 2
- XLogP
- 2.4
- TPSA
- 112 Ų
- H-bond donors
- 2
- H-bond acceptors
- 6
- Rotatable bonds
- 5
- Heavy atoms
- 30
SMILES CC1=NC2=C(C=C1)C=C(C=C2)CN3C=C(N=N3)C(=O)NCC4=C(N=C(C=C4C)N)C
Computed descriptors from PubChem (CID 58081326), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il